GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Cyclically Adjusted Revenue per Share

Amicogen (XKRX:092040) Cyclically Adjusted Revenue per Share : ₩2,544.52 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Amicogen's adjusted revenue per share for the three months ended in Dec. 2023 was ₩1,256.479. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩2,544.52 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Amicogen's average Cyclically Adjusted Revenue Growth Rate was 18.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-05-12), Amicogen's current stock price is ₩7450.00. Amicogen's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was ₩2,544.52. Amicogen's Cyclically Adjusted PS Ratio of today is 2.93.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Amicogen was 5.99. The lowest was 2.18. And the median was 3.69.


Amicogen Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Amicogen's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Cyclically Adjusted Revenue per Share Chart

Amicogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 2,152.22 2,544.52

Amicogen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,152.22 2,245.13 2,322.23 2,448.45 2,544.52

Competitive Comparison of Amicogen's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Amicogen's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amicogen's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amicogen's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Amicogen's Cyclically Adjusted PS Ratio falls into.



Amicogen Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Amicogen's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1256.479/118.8477*118.8477
=1,256.479

Current CPI (Dec. 2023) = 118.8477.

Amicogen Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 74.089 99.253 88.716
201406 142.804 99.353 170.825
201409 153.641 99.608 183.317
201412 271.981 99.098 326.185
201503 140.504 99.720 167.455
201506 130.528 100.050 155.052
201509 88.777 100.110 105.393
201512 461.128 100.220 546.837
201603 482.904 100.560 570.724
201606 396.394 100.790 467.413
201609 270.099 101.460 316.387
201612 559.235 101.560 654.429
201703 412.743 102.850 476.943
201706 221.724 102.610 256.811
201709 188.451 103.490 216.417
201712 588.367 102.990 678.960
201803 350.517 104.100 400.174
201806 508.264 104.130 580.102
201809 607.571 105.650 683.468
201812 479.136 104.350 545.704
201903 618.378 104.490 703.348
201906 586.655 104.880 664.784
201909 497.565 105.200 562.115
201912 1,727.066 105.120 1,952.605
202003 605.662 105.540 682.031
202006 728.135 104.870 825.185
202009 704.304 106.200 788.182
202012 740.954 105.765 832.604
202103 735.552 107.357 814.279
202106 753.610 107.579 832.552
202109 562.303 108.759 614.462
202112 890.701 109.676 965.183
202203 689.682 111.806 733.120
202206 759.902 114.083 791.641
202209 897.235 114.831 928.617
202212 1,022.158 115.200 1,054.522
202303 891.983 116.550 909.571
202306 923.947 117.140 937.417
202309 1,007.386 119.111 1,005.157
202312 1,256.479 118.848 1,256.479

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Amicogen  (XKRX:092040) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Amicogen's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=7450.00/2544.52
=2.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Amicogen was 5.99. The lowest was 2.18. And the median was 3.69.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Amicogen Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Amicogen's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Amicogen (XKRX:092040) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Amicogen, Inc. is an industrial biotechnology company operating in Korea. It is engaged in development, production and distribution of enzymes, bio new materials and healthcare food. The company's products portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins.

Amicogen (XKRX:092040) Headlines

No Headlines